Alexandre Gaudet

ORCID: 0000-0003-3787-8135
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammation biomarkers and pathways
  • Respiratory Support and Mechanisms
  • COVID-19 Clinical Research Studies
  • Pancreatitis Pathology and Treatment
  • Sepsis Diagnosis and Treatment
  • Nosocomial Infections in ICU
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Apelin-related biomedical research
  • Intensive Care Unit Cognitive Disorders
  • Cardiac Arrest and Resuscitation
  • Diabetes and associated disorders
  • Pneumonia and Respiratory Infections
  • Neonatal Respiratory Health Research
  • Mechanical Circulatory Support Devices
  • Cardiovascular Health and Disease Prevention
  • Non-Invasive Vital Sign Monitoring
  • Thermal Regulation in Medicine
  • Hemodynamic Monitoring and Therapy
  • Chronic Kidney Disease and Diabetes
  • Ion Transport and Channel Regulation
  • Heart Failure Treatment and Management
  • Ultrasound in Clinical Applications
  • Anesthesia and Neurotoxicity Research
  • Healthcare Decision-Making and Restraints

Université de Lille
2017-2024

Centre Hospitalier Universitaire de Lille
2017-2024

Center for Infection and Immunity of Lille
2017-2024

Institut Pasteur de Lille
2017-2024

Centre National de la Recherche Scientifique
2017-2024

Inserm
2017-2024

Stanford University
2021-2024

Hôpital Roger Salengro
2017-2024

Centre Hospitalier de Béthune
2023

Unité de Glycobiologie Structurale et Fonctionnelle
2022

Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16

Recent multicenter studies identified COVID-19 as a risk factor for invasive pulmonary aspergillosis (IPA). However, no large study has compared the incidence of IPA between and influenza patients.To determine putative in critically ill SARS-CoV-2 patients, with patients.This was planned ancillary analysis coVAPid retrospective European cohort. Consecutive adult patients requiring mechanical ventilation > 48 h pneumonia or were included. The 28-day cumulative IPA, based on Blot definition,...

10.1186/s13054-021-03874-1 article EN cc-by Critical Care 2022-01-04

Prone positioning (PP) reduces mortality of patients with acute respiratory distress syndrome (ARDS). The potential benefit prone maneuvers during venovenous extracorporeal membrane oxygenation (ECMO) is unknown. aim this study was to evaluate the association between use support and ICU in a pooled population from previous European cohort studies.We performed individual patient data analysis studies which compared treated ECMO (Prone group) "conventional" management (Supine severe ARDS.889...

10.1186/s13054-021-03879-w article EN cc-by Critical Care 2022-01-06
Marius Trøseid José Ramón Arribas Lambert Assoumou Aleksander Rygh Holten Julien Poissy and 95 more Vida Terzić Fulvia Mazzaferri Jesús Rodríguez‐Baño Joe Eustace Maya Hites Michael Joannidis José Artur Paiva Jean Reuter Isabel Püntmann Thale D.J.H. Patrick-Brown Elin Westerheim Kateřina Nezvalová‐Henriksen Lydie Béniguel Tuva B. Dahl Maude Bouscambert Monika Halanova Zoltán Péterfi Sotirios Tsiodras Michael Rezek Matthias Briel Serhat Ünal Martin Schlegel Florence Ader Karine Lacombe Cecilie Delphin Amdal S. Vicente Rodrigues Kristian Tonby Alexandre Gaudet Lars Heggelund Joy Mootien Asgeir Johannessen Jannicke Horjen Møller Beatriz Díaz‐Pollán Anders Tveita Anders Benjamin Kildal Jean‐Christophe Richard Olav Dalgård Victoria Charlotte Simensen Aliou Baldé Lucie de Gastines Marta del Álamo Burç Aydın Fridtjof Lund‐Johansen Mary‐Anne Trabaud Alpha Diallo Bente Halvorsen John-Arne Røttingen Evelina Tacconelli Yazdan Yazdanpanah Inge Christoffer Olsen Dominique Costagliola Anne Ma Dyrhol‐Riise Birgitte Stiksrud Synne Jenum Magnhild E. Macpherson Nikolai Ravn Aarskog Kjerstin Røstad Linda Gail Skeie Åsne Dahl Jeanette Konstance Steen Sarah Nur Filip M. Segers Katrine Andersen Korsan Ashwini Sethupathy Ann Jorunn Sandstå Gunn-Janne Paulsen Thor Ueland Annika E. Michelsen Pål Aukrust Jan‐Erik Berdal Ingunn Melkeraaen Merete Moen Tollefsen J. Andreassen Jannicke Dokken Karl Erik Müller Bjørn Martin Woll Hanne Opsand Mette Bogen Linn-Therese Rød Trude Steinsvik Bjørn Åsheim-Hansen Randi Haukaas Bjerkreim Åse Berg Solfrid Moen Stina Kvalheim Kristian Strand Berit Gravrok Vegard Skogen Elias Myrvoll Lorentzen Simen W. Schive L. Rossvoll Hedda Hoel Simon Engebråten Mia Schie Martinsson Monica Thallinger

Abstract Background Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. Methods Bari-SolidAct is a phase-3, multicentre, randomised, double-blind, trial, enrolling participants from June 3, 2021 to March 7, 2022, stopped prematurely for external evidence. Patients COVID-19 were randomised 4 mg once daily or placebo, added standard of care. The primary...

10.1186/s13054-022-04205-8 article EN cc-by Critical Care 2023-01-10

La polymerase chain reaction (PCR) est une technique de biologie moléculaire d’importance fondamentale qui permet détecter et quantifier des fragments spécifiques d’acides nucléiques. En combinant plusieurs primers dans même réaction, il possible manière simultanée cibles moléculaires distinctes, ce défi nit la PCR multiplex (mPCR). L’application plus fréquente en réanimation concerne le diagnostic syndromique infections, rendu par outils diagnostiques multicibles permettent détection...

10.37051/mir-34-001951 article FR Médecine Intensive Réanimation 2025-02-23

Abstract Background Differentiating Ventilator-Associated Tracheobronchitis (VAT) from Pneumonia (VAP) may be challenging for clinicians, yet their management currently differs. In this study, we evaluated the accuracy of Clinical Pulmonary Infection Score (CPIS) to differentiate VAT and VAP. Methods We performed a retrospective analysis based on data 2 independent prospective cohorts. Patients TAVeM database with diagnosis ( n = 320) or VAP 369) were included in derivation cohort. admitted...

10.1186/s13613-020-00721-4 article EN cc-by Annals of Intensive Care 2020-08-03

Acute respiratory distress syndrome is a severe form of failure, occurring in up to 20% patients admitted the intensive care unit with sepsis. Dysregulated leukocyte diapedesis major contributor acute syndrome. Endocan circulating proteoglycan that binds integrin functional antigen-1 and blocks its interaction endothelial ligand, ICAM-1. The objective this study was evaluate role endocan control lung inflammation. In vitro, inhibited human transendothelial migration as well ICAM-1-dependent...

10.1152/japplphysiol.00337.2019 article EN Journal of Applied Physiology 2019-07-11

Abstract Dysregulated leukocyte diapedesis is a major contributor to acute severe inflammatory states like sepsis and respiratory distress syndrome, which are common conditions in critically ill subjects. Endocan circulating proteoglycan that binds the integrin LFA-1 blocks its interaction with endothelial ligand ICAM-1, subsequently leading inhibition of recruitment. Recent data have highlighted hypothetic role p14, endocan's catabolite found bloodstream septic patients, as potential...

10.1002/jlb.3ab0320-612rr article EN Journal of Leukocyte Biology 2020-04-09

Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed evaluate influence socio-economic status on COVID-19 ARDS. carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled Berlin criteria. For patients...

10.1007/s00134-023-07180-y article EN cc-by-nc Intensive Care Medicine 2023-08-24

We aimed to compare the outcomes of patients under veno-venous extracorporeal membrane oxygenation (V-V ECMO) for COVID-19-Acute Respiratory Distress Syndrome (CARDS) between first and second wave. From 1 March 2020 30 November 2020, fifty requiring a V-V ECMO support CARDS were included. Patient demographics, pre-ECMO, day one, three, seven on-ECMO data collected. The 90-day mortality was 11% higher during wave (18/26 (69%)) compared (14/24 (58%) (p = 0.423). During wave, all given steroids...

10.3390/jcm10214839 article EN Journal of Clinical Medicine 2021-10-21

Esm-1 is primarily expressed in glomerular endothelium humans. Cells expressing Esm1 exhibit a high degree of conservation the enrichment genes related to blood vessel development. In context diabetes, these cells are reduced number and show significant transcriptional shift toward chemotaxis pathway. there polarization glomerulus that reflected by deficiency.

10.1152/ajprenal.00419.2023 article EN AJP Renal Physiology 2024-04-11

Predictive scores assessing the risk of respiratory failure in COVID-19 mostly focused on prediction early intubation. A combined assessment clinical parameters and biomarkers endotheliopathy could allow to predict late worsening acute (ARF), subsequently warranting intubation COVID-19. Retrospective single-center derivation (n = 92 subjects) validation cohorts 59 subjects), including severe patients with non-invasive support, were assessed for at least 48 h following intensive care unit...

10.3390/jcm11082172 article EN Journal of Clinical Medicine 2022-04-13

Background: Acute respiratory distress syndrome (ARDS) is a life-threatening condition resulting from acute pulmonary inflammation. However, no specific treatment for ARDS has yet been developed. Previous findings suggest that lung injuries related to could be regulated by endocan (Esm-1). The aim of this study was evaluate the potential efficiency in ARDS. Methods: We first compared features inflammation and severity hypoxemia tracheal LPS-induced injury (ALI) model performed knockout...

10.3390/cells12020257 article EN cc-by Cells 2023-01-07
Coming Soon ...